Synovus Financial Corp Astrazeneca PLC Transaction History

Synovus Financial Corp

$8.55 Billion
Q3 2025

A detailed history of Synovus Financial Corp transactions in Astrazeneca PLC stock. As of the latest transaction made, Synovus Financial Corp holds 78,315 shares of AZN stock, worth $7 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

78,315

Previous 70,732 10.72%

Holding current value

$7 Million

Previous $4.94 Million 21.57%

% of portfolio

0.07%

Previous 0.06%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 07, 2025	BUY	$68.72 - $82.11 $521,103 - $622,640	7,583 Added 10.72%	78,315 $6.01 Million
Q2 2025 Aug 14, 2025	BUY	$64.87 - $75.0 $381,565 - $441,150	5,882 Added 9.07%	70,732 $4.94 Million
Q1 2025 May 14, 2025	BUY	$65.37 - $77.96 $139,499 - $166,366	2,134 Added 3.4%	64,850 $4.77 Million
Q4 2024 Feb 13, 2025	SELL	$63.2 - $79.58 $135,500 - $170,619	-2,144 Reduced 3.31%	62,716 $4.11 Million
Q3 2024 Nov 14, 2024	SELL	$76.67 - $87.62 $307,216 - $351,093	-4,007 Reduced 5.82%	64,860 $5.05 Million

Q2 2024 Aug 13, 2024	SELL	$66.81 - $80.83 $72,355 - $87,538	-1,083 Reduced 1.55%	68,867 $5.37 Million
Q1 2024 May 14, 2024	SELL	$61.03 - $69.57 $4.86 Million - $5.54 Million	-79,620 Reduced 53.23%	69,950 $4.74 Million
Q3 2023 Nov 13, 2023	SELL	$64.85 - $71.7 $371,071 - $410,267	-5,722 Reduced 3.68%	149,570 $10.1 Million
Q2 2023 Aug 08, 2023	BUY	$69.91 - $75.81 $141,777 - $153,742	2,028 Added 1.32%	155,292 $11.1 Million
Q1 2023 May 11, 2023	BUY	$63.15 - $71.6 $122,447 - $138,832	1,939 Added 1.28%	153,264 $10.6 Million
Q4 2022 Feb 06, 2023	BUY	$54.21 - $70.44 $84,025 - $109,182	1,550 Added 1.03%	151,325 $10.3 Million
Q3 2022 Oct 27, 2022	BUY	$53.02 - $135.75 $298,184 - $763,458	5,624 Added 3.9%	149,775 $8.2 Million
Q2 2022 Aug 10, 2022	BUY	$59.26 - $71.14 $605,400 - $726,766	10,216 Added 7.63%	144,151 $9.53 Million
Q1 2022 May 12, 2022	BUY	$55.72 - $67.12 $184,600 - $222,368	3,313 Added 2.54%	133,935 $8.89 Million
Q4 2021 Feb 14, 2022	BUY	$54.02 - $63.83 $373,332 - $441,129	6,911 Added 5.59%	130,622 $7.61 Million
Q3 2021 Nov 08, 2021	BUY	$55.56 - $60.79 $175,958 - $192,521	3,167 Added 2.63%	123,711 $7.44 Million
Q2 2021 Aug 11, 2021	BUY	$48.42 - $60.18 $45,321 - $56,328	936 Added 0.78%	120,544 $7.22 Million
Q1 2021 May 11, 2021	BUY	$47.16 - $54.44 $196,044 - $226,307	4,157 Added 3.6%	119,608 $5.95 Million
Q4 2020 Feb 11, 2021	BUY	$48.52 - $58.02 $96,603 - $115,517	1,991 Added 1.75%	115,451 $5.77 Million
Q3 2020 Nov 09, 2020	SELL	$53.07 - $61.1 $49,514 - $57,006	-933 Reduced 0.82%	113,460 $6.21 Million
Q2 2020 Aug 10, 2020	SELL	$43.1 - $55.31 $3.31 Million - $4.24 Million	-76,689 Reduced 40.13%	114,393 $6.05 Million
Q1 2020 Apr 24, 2020	BUY	$37.79 - $51.33 $3.32 Million - $4.51 Million	87,862 Added 85.12%	191,082 $8.51 Million
Q4 2019 Feb 06, 2020	BUY	$42.46 - $50.46 $511,260 - $607,588	12,041 Added 13.21%	103,220 $5.15 Million
Q3 2019 Nov 01, 2019	BUY	$40.12 - $45.47 $812,871 - $921,267	20,261 Added 28.57%	91,179 $4.06 Million
Q2 2019 Aug 08, 2019	BUY	$37.28 - $41.68 $2.54 Million - $2.84 Million	68,161 Added 2472.29%	70,918 $2.93 Million
Q1 2019 May 09, 2019	SELL	$35.49 - $43.02 $60,191 - $72,961	-1,696 Reduced 38.09%	2,757 $111,000
Q4 2018 Feb 07, 2019	BUY	$36.86 - $41.49 $17,434 - $19,624	473 Added 11.88%	4,453 $168,000
Q3 2018 Nov 01, 2018	SELL	$34.76 - $39.72 $67,017 - $76,580	-1,928 Reduced 32.63%	3,980 $159,000
Q2 2018 Aug 01, 2018	BUY	$34.55 - $37.05 $20,349 - $21,822	589 Added 11.07%	5,908 $208,000
Q1 2018 May 07, 2018	SELL	$32.97 - $36.63 $135,111 - $150,109	-4,098 Reduced 43.52%	5,319 $186,000
Q4 2017 Feb 09, 2018	BUY	$32.09 - $34.78 $302,191 - $327,523	9,417	9,417 $327,000

Others Institutions Holding AZN

# of Institutions

1,501

Shares Held

500M

Call Options Held

5.59M

Put Options Held

3.18M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $277B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Synovus Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Synovus Financial Corp with notifications on news.

Account

Synovus Financial Corp Astrazeneca PLC Transaction History